Public Health
Reducing childhood sugar-sweetened beverage consumption
On February 23, the Engelberg Center for Health Care Reform convened the third meeting on the topic of improving patient medication information (PMI). While previous discussions focused on the content and format of the single-page PMI document, this meeting focused on the process of delivering PMI to patients, a process that currently is both inconsistent and unreliable. Several independent groups presented outlines for potential distribution pilots and experts commented on pilot design, implementation of pilots, and proposed strategies to evaluate distribution through pilots. These pilots will test distribution of PMI for real products to real patients.
Discussion specifically focused on:
- What researchers have learned about how medication information is currently distributed, particularly within the current pharmacy work-flow
- Types of medical products that would be suitable for pilots
- How to create accompanying PMI prototypes
- What the community can hope to learn from such pilots
- Appropriate metrics for evaluating the distribution process
Agenda
-
February 23
-
Welcome, Overview, and Meeting Objectives
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University -
FDA Perspectives: Past and Future for PMI
JWJanet Woodcock Director, Center for Drug Evaluation and Research - US Food and Drug AdministrationRBRachel Behrman Director, Office of Medical Policy, Center for Drug Evaluation and Research -
Session I: Goals and Objectives of PMI Distribution Pilots
MWMichael Wolf Professor of Medicine, Feinberg School of Medicine - Northwestern UniversityRPRuth Parker Emory University School of MedicineMSPMark S. Paxton Pharmaceutical Research and Manufacturers of America -
Session II: Developing PMI for Use in Pilots
TGCThomas G. Cantu GlaxoSmithKlinePBPamela Budny Eli Lilly and CompanyGCGail Cawkwell Pfizer, Inc. -
Session III: Potential Distribution Pilots
BBBaxter Byerly Catalina Health ResourceMSMike Skovira Catalina Health ResourceRTRussell Teagarden Vice President, Clinical Practices & Therapeutics, Medco Health Solutions, Inc.EFEdward Fotsch Chief Executive Officer - PDR NetworkSJNStuart J. Nelson National Library of Medicine -
Moderated Discussion
GKMGerald K. McEvoy American Society of Health-System PharmacistsWSWilliam Shrank Harvard Medical School and Brigham & Women's HospitalMMMichael Murray Regenstrief Center for Healthcare Improvement and Research, Regenstrief Institute, Inc. -
Closing Remarks
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University
-
